8-70706933-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001011720.2(XKR9):c.273G>T(p.Arg91Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,607,428 control chromosomes in the GnomAD database, including 2 homozygotes. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00077 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 2 hom. )
Consequence
XKR9
NM_001011720.2 missense, splice_region
NM_001011720.2 missense, splice_region
Scores
7
8
4
Splicing: ADA: 0.9769
2
Clinical Significance
Conservation
PhyloP100: 2.57
Genes affected
XKR9 (HGNC:20937): (XK related 9) Predicted to enable phospholipid scramblase activity. Predicted to be involved in apoptotic process involved in development; engulfment of apoptotic cell; and phosphatidylserine exposure on apoptotic cell surface. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XKR9 | NM_001011720.2 | c.273G>T | p.Arg91Ser | missense_variant, splice_region_variant | 4/5 | ENST00000408926.8 | NP_001011720.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XKR9 | ENST00000408926.8 | c.273G>T | p.Arg91Ser | missense_variant, splice_region_variant | 4/5 | 1 | NM_001011720.2 | ENSP00000386141 | P1 | |
XKR9 | ENST00000520030.5 | c.273G>T | p.Arg91Ser | missense_variant, splice_region_variant | 5/6 | 1 | ENSP00000431088 | P1 | ||
XKR9 | ENST00000520273.1 | n.132G>T | splice_region_variant, non_coding_transcript_exon_variant | 2/4 | 3 | |||||
XKR9 | ENST00000520092.5 | c.*13G>T | splice_region_variant, 3_prime_UTR_variant, NMD_transcript_variant | 5/6 | 2 | ENSP00000430781 |
Frequencies
GnomAD3 genomes AF: 0.000770 AC: 117AN: 152038Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
117
AN:
152038
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000490 AC: 122AN: 249130Hom.: 0 AF XY: 0.000423 AC XY: 57AN XY: 134906
GnomAD3 exomes
AF:
AC:
122
AN:
249130
Hom.:
AF XY:
AC XY:
57
AN XY:
134906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00118 AC: 1711AN: 1455272Hom.: 2 Cov.: 30 AF XY: 0.00114 AC XY: 829AN XY: 724228
GnomAD4 exome
AF:
AC:
1711
AN:
1455272
Hom.:
Cov.:
30
AF XY:
AC XY:
829
AN XY:
724228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000769 AC: 117AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.000726 AC XY: 54AN XY: 74382
GnomAD4 genome
AF:
AC:
117
AN:
152156
Hom.:
Cov.:
33
AF XY:
AC XY:
54
AN XY:
74382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
5
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
13
ExAC
AF:
AC:
57
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.273G>T (p.R91S) alteration is located in exon 4 (coding exon 2) of the XKR9 gene. This alteration results from a G to T substitution at nucleotide position 273, causing the arginine (R) at amino acid position 91 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MutPred
Loss of MoRF binding (P = 0.0159);Loss of MoRF binding (P = 0.0159);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at